Superworth

MBX Biosciences price to book ratio MBX

Market value divided by the book value of the company's net assets, since 2024.

Today, Oct 23, 2026
5.7×
Peer median
3.2×

MBX Biosciences' price to book ratio is 5.7× as of Oct 23, 2026.

The median for 10 large drugmakers of a similar size is 3.2×.

Price to book ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far5.7×3.3×8.1×
20253.6×0.8×4.0×
20242.5×2.2×2.8×

Against its peers

Companies in Drug Manufacturers - General nearest MBX Biosciences' size, closest first, today.

CompanyPrice to book ratio
MBXMBX Biosciences5.7×
PBHPrestige Consumer Healthcare1.2×
HRMYHarmony Biosciences2.1×
NRIXNurix Therapeutics2.9×
ANIPANI Pharmaceuticals2.8×
PAHCPhibro Animal Health4.1×
OGNOrganon3.6×
ANABAnaptysbio138×
PCRXPacira BioSciences2.2×
LQDALiquidia19.6×
ARQTArcutis Biotherapeutics17.8×
Peer median3.2×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on MBX Biosciences

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.